CA Stock MarketDetailed Quotes
RVV Revive Therapeutics Ltd
- 0.010
- 0.0000.00%
15min DelayTrading Jul 2 09:30 ET
3.58MMarket Cap-500P/E (TTM)
0.010High0.010Low716.00KVolume0.010Open0.010Pre Close7.16KTurnover0.06052wk High0.20%Turnover Ratio358.45MShares0.00552wk Low-0.02EPS TTM3.58MFloat Cap0.960Historical HighLossP/E (Static)358.45MShs Float0.005Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM0.37P/B1Lot Size--Div YieldTTM
Revive Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -5.31%1.86M | -48.86%783.56K | -75.30%413.53K | -69.04%5.52M | -87.31%355K | -67.50%1.96M | -62.77%1.53M | -65.77%1.67M | -4.08%17.83M | -60.86%2.8M |
| Selling and administrative expenses | 59.43%1.38M | 3.83%278.83K | -40.45%252.66K | -28.84%1.77M | -41.65%213.65K | 196.57%866.92K | -77.69%268.55K | -32.67%424.25K | -78.42%2.49M | -92.12%366.19K |
| -Selling and marketing expense | -58.23%131K | ---- | ---- | 3,717.89%313.64K | --0 | 4,609.31%313.64K | ---- | ---- | -97.01%8.22K | --1.56K |
| -General and administrative expense | 126.14%1.25M | 3.83%278.83K | -40.45%252.66K | -41.23%1.46M | -41.41%213.65K | 93.69%553.28K | -77.69%268.55K | -32.67%424.25K | -77.96%2.48M | -92.15%364.63K |
| Research and development costs | -55.53%471.96K | -65.16%433.22K | -88.49%133.39K | -76.36%3.58M | -94.95%119.32K | -81.41%1.06M | -56.52%1.24M | -72.56%1.16M | 126.05%15.16M | -4.35%2.36M |
| Depreciation amortization depletion | -24.07%82 | -24.77%82 | -24.07%82 | -24.91%434 | -24.83%109 | -25.00%108 | -24.83%109 | -25.00%108 | -25.42%578 | -25.26%145 |
| -Depreciation and amortization | -24.07%82 | -24.77%82 | -24.07%82 | -24.91%434 | -24.83%109 | -25.00%108 | -24.83%109 | -25.00%108 | -25.42%578 | -25.26%145 |
| Other operating expenses | -95.45%1.42K | 251.63%71.42K | -69.73%27.4K | -11.06%163.98K | -67.70%21.92K | 8.49%31.24K | -60.87%20.31K | 152.87%90.51K | -45.75%184.37K | 108.01%67.87K |
| Operating profit | 5.31%-1.86M | 48.86%-783.56K | 75.30%-413.53K | 69.04%-5.52M | 87.31%-355K | 67.50%-1.96M | 62.77%-1.53M | 65.77%-1.67M | 4.08%-17.83M | 60.86%-2.8M |
| Net non-operating interest income (expenses) | -98.09%297 | 77.20%12.93K | 54.53%22.9K | 22.37%64.61K | 186.07%26.95K | 147.41%15.55K | -57.53%7.3K | -25.56%14.82K | 197.43%52.8K | -60.76%9.42K |
| Non-operating interest income | -80.04%5.3K | -2.51%19.61K | 7.04%31.38K | -8.43%112.79K | 47.94%36.81K | 13.88%26.54K | -43.66%20.12K | -25.34%29.32K | 19.48%123.16K | -43.16%24.88K |
| Non-operating interest expense | -59.16%4.23K | -49.54%5.9K | -42.34%7.48K | -30.63%44K | -36.85%8.96K | -32.43%10.36K | -28.80%11.7K | -25.72%12.97K | -19.70%63.42K | -23.00%14.19K |
| Total other finance cost | 21.71%768 | -30.68%775 | -34.56%996 | -39.84%4.18K | -29.10%904 | -62.57%631 | -46.40%1.12K | -19.60%1.52K | 9.38%6.94K | -5.35%1.28K |
| Other net income (expenses) | -16.62K | -3,137.71%-864.5K | 98.27%-26.7K | |||||||
| Gain on sale of security | ---36.62K | ---- | ---- | ---87.5K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --20K | ---- | ---- | -2,810.00%-777K | ---777K | --0 | ---- | ---- | 98.45%-26.7K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --777K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---20K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.45%26.7K | ---- |
| Income before tax | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M |
| Net income continuous operations | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 3.71%-1.87M | 49.47%-770.62K | 76.46%-390.62K | 64.50%-6.32M | 57.64%-1.19M | 67.72%-1.94M | 62.79%-1.52M | 65.93%-1.66M | 11.49%-17.81M | 68.19%-2.82M |
| Diluted earnings per share | 17.86%-0.0048 | 54.11%-0.0022 | 89.08%-0.0011 | 66.67%-0.02 | 0.00%-0.01 | 70.66%-0.0059 | 53.06%-0.0047 | 50.00%-0.01 | 25.00%-0.06 | 66.67%-0.01 |
| Basic earnings per share | 17.86%-0.0048 | 54.11%-0.0022 | 89.08%-0.0011 | 66.67%-0.02 | 0.00%-0.01 | 70.66%-0.0059 | 53.06%-0.0047 | 50.00%-0.01 | 25.00%-0.06 | 66.67%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg